Penile metastasis from prostate adenocarcinoma is rare and the disease is usually disseminated at presentation. We present a case of an 83-year-old man with solitary metastasis to the penis from prostate adenocarcinoma. The clinical presentation and imaging features of penile metastasis from prostate cancer and the other primary penile tumors are discussed.
CASE REPORT
An 83-year-old man presented with a painless lump at the base of the penis for a few months. He also complained of lower urinary tract symptoms.
On examination, there was a non-tender hard lump at the right base of the penis which was tethered to the deep tissue. No focal prostate mass was detected on digital rectal examination.
Dedicated penile magnetic resonance imaging (MRI) revealed an enhancing 2.1 x 1.1 x 1.3 cm right corpus cavernosal nodule along the mid-shaft of the penis (Fig. 1 ). It appeared locally aggressive with infiltration of the enveloping tunica albuginea. Overlying skin was not involved. It returned T1-weighted isointense and T2-weighted hypointense signals. Incidentally, the partially imaged prostate showed a left-sided heterogeneous mass which replaced the normal T2-weighted hyperintense signal of the peripheral zone and focally disrupted the T2-weighted hypointense capsule at the left posterolateral corner (Fig. 2) .
He subsequently underwent ultrasound-guided core needle biopsy of the penile lump. Targeted ultrasound (US) during biopsy demonstrated an infiltrative heterogeneous iso-hypoechoic nodule in the right corpus cavernosum with associated internal vascularity ( Fig. 3 ). Histology revealed poorly differentiated carcinoma. Immunohistochemical staining with prostatic specific acid phosphatase and α-Methylacyl CoA racemase were positive ( Fig. 4) .
He also underwent a channel transurethral resection of the prostate to treat his bladder outlet obstruction. Histology showed acinar adenocarcinoma (Gleason score 4 + 5) ( Fig. 4) . The prostate-specific-antigen level was elevated at 303 µg/L. Computed tomography (CT) intravenous pyelography did not reveal any other distant metastasis or nodal disease ( Fig.  5 ).
Whole-body bone scan performed showed no evidence of osteoblastic bony metastases ( Fig. 6 ). Treatment options were discussed and he opted for hormonal treatment.
Etiology & Demographics:
To the best of the authors' knowledge, there has been no reported case of isolated metastasis to the penis from prostate CASE REPORT DISCUSSION cancer. A plausible explanation for its presumed low incidence may be because imaging for prostate cancer (i.e. MRI prostate) does not typically include the penis. The actual incidence may therefore be higher. Nevertheless, the most common penile metastasis still arises from the urogenital tract [1] . Several proposed mechanisms for prostate cancer metastasis to the penis include direct invasion, implantation (from prior instrumentation), retrograde venous flow, arterial or lymphatic dissemination. Retrograde venous flow is deemed the most common pathway, with the spread of tumor cells facilitated by transient episodes of increased intraabdominal pressure (for example, during coughing or straining) [2] . Not unexpectedly, most of penile metastases are located in the corpora cavernosa [2] [3] . These contain venous sinuses which are drained via the emissary veins, subsequently into the cavernosal veins, deep dorsal or spongiosal vein of the penis, and eventually into the prostatic venous plexus or the internal pudendal vein [3] [4] .
The median age reported for penile metastases from prostate cancer ranged from 65 to 75 years old [1, 5] . Most of these patients already had bony metastases when they present with penile metastases [1] . Established risk factors for prostate cancer are age, African American ethnicity and family history [6] .
Clinical & Imaging Findings:
Patients can present with penile pain, ulceration, palpable penile nodule, priapism and/or urinary symptoms such as urinary retention, dysuria and hematuria [2, 7] . Digital rectal examination may reveal an enlarged hard nodular prostate.
US imaging of the penis typically demonstrates hypoechoic or heterogeneous nodules in the corpora cavernosa and/or corpus spongiosum, associated with vascularity on color Doppler [8] . On MRI, these nodules are of low signal intensity on the T1-and T2-weighted sequences and show enhancement on the post-contrast sequence [2, 9] . The primary tumor, as in this case of a prostate adenocarcinoma, may be included in the field of view.
Treatment & Prognosis:
Treatment options for metastatic prostate cancer are dependent on patient clinical status and disease burden. These include chemotherapy, radiotherapy, hormonal therapy (for example, gonadotropin-releasing hormone analogue and androgen receptor inhibitor) or surgical orchiectomy. Partial or total penectomy may be performed for patients with priapism or uncontrollable pain [7] . In selected patients with metastatic castration-resistant prostate cancer, on-going clinical trials using Lutetium-177-porstate-specific membrane antigen radionuclide therapy have shown encouraging results.
Prognosis is very poor as patients usually present with disseminated disease. The average survival is reported to be 6 months upon presentation [7] .
Differential Diagnoses:
The main differential diagnosis will be squamous cell carcinoma (SCC), which is the most common primary tumor of the penis, accounting for 95% of all primary penile tumors [9] . There is an association with human papilloma viruses 16 and 18 [10] . It typically presents as a painless skin nodule, with or without associated ulceration [11] . Unlike penile metastases, which are typically located in the corpora cavernosa and do not usually involve the skin, SCCs invariably start at the skin and commonly occur at the glans penis [9] . As SCCs are clinically evident, additional imaging is usually not required. On MRI, SCC appears hypointense relative to the corpora on T1-and T2-weighted sequences and enhances less than the corporal bodies [9] .
Primary penile sarcomas (e.g. epithelioid sarcomas, Kaposi sarcomas, leiomyosarcomas and rhabdomyosarcomas) are rare and account for less than 5% of penile tumors. Clinically, one can manifest as a focal induration or palpable mass [11] . MRI appearances of the various sarcomas are varied and non-specific, with no predisposition for certain locations. In general, they show T2-weighted hyperintensity and enhance avidly on post-contrast sequence. They often appear heterogeneous due to internal hemorrhage and necrosis [12] .
Anterior urethral carcinoma, most commonly SCC followed by transitional cell carcinoma and adenocarcinoma, can involve the corpus spongiosum and corpus cavernosum through direct extension. It accounts for less than 1% of the urogenital malignancies [13] . Predisposing factors include urethral stricture, chronic inflammation or sexually transmitted disease [14] . Patients commonly present with a palpable penile mass with or without obstruction symptoms. They can also present with urethral stricture, bleeding, urethral discharge, urethral fistula, perineal pain, periurethral abscess or urinary symptoms. MR findings include hypointense mass relative to the corpora on T1-and T2-weight imaging [15] .
Primary lymphoma of the penis, most commonly of Bcell origin, is extremely rare [16] . Patient can present with non-healing ulcer, palpable nodule, urethral stricture or periurethral abscess [17] . It commonly involves the corporal bodies followed by the glans penis [16] . On MRI, the lesion is homogeneously isointense on T1-and T2-weighted sequences and shows minimal enhancement [18] . It demonstrates avid uptake on 18Fluorine-fluorodeoxyglucose-positron emission tomography/ computed tomography (18F-FDG-PET/CT) [12] .
Peyronie's disease is a benign condition of the penis due to fibrosis of the tunica albuginea from chronic inflammation, which can manifest as a penile mass. Patients often present with focal induration, curvature of the penis and/or pain. The plaques may calcify. On MRI, the plaques appear as hypointense areas of thickening in the tunica albuginea on the T1-and T2-weighted sequences [11, 19] . Enhancement of the plaque indicates active inflammation [11, 19] .
Solitary metastasis to the penis from prostate adenocarcinoma is rare, with the more common primary penile squamous cell carcinoma being the main differential diagnosis. On imaging, penile metastases typically arise from the corpora cavernosa, as opposed to squamous cell carcinoma which typically involves the skin of the glans penis. One should always review the urogenital tract (i.e. prostate, bladder) for any incidental primary tumor in the presence of a penile lesion on MRI. 
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